A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery
NCT00301535
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DRUG:
HBOC-201 (hemoglobin glutamer-250 bovine)
Sponsor
Biopure Corporation